When addressing unexpected adverse events in clinical trials, I think a combination of predefined protocols and event-specific flexibility is essential. Standardized guidelines set a clear baseline for accountability and efficiency, ensuring everyone knows their roles and responsibilities in routine scenarios….   Read more»